Friday 19 March 2010 Media Standards Trust

RSS feedAndrew Jack

  • Andrew Jack has written articles published in Financial Times (Pharmaceuticals Correspondent, Pharmaceutical Correspondent).
  • Email Andrew Jack at:

Most Recent article

Making a virtue of patients

Financial Times, Tuesday 16 March
When Novartis, the Swiss pharmaceuticals company, looked for patients in the UK four years ago to test a promising experimental medicine for multiple sclerosis, it stumbled across obstacles that help explain the country's decline as a centre for international drug development.
Original article at Financial Times

Previous Articles

Published on one or more of 14 websites.

(Show all 836 articles)

Article(s) missing? If you notice an article is missing, click here

Andrew Jack has written...

  • More about 'gsk' than anything else
  • A lot about 'merck' in the last month

Andrew Jack by numbers...

  • 836 articles (since January 2008)
  • Average article: 15 column inches (460 words)
  • Shortest article: 1 column inches (33 words)
  • Longest article: 125 column inches (3753 words)
(what are column inches?)
Caution: this list is not comprehensive but based on articles published in 21 UK news outlets across 14 different websites. The information is collected automatically so there are bound to be mistakes. Please let us know when you find one so we can correct it.
Email me when Andrew Jack writes an article

More useful links for Andrew Jack

Suggest a link for Andrew Jack

The topics Andrew Jack mentions most:

 astrazeneca   aventis   eu   europe   european   fda   genentech   glaxosmithkline   gsk   hiv   london   merck   nhs   novartis   pfizer   roche   sanofi   sk   witty   wyeth 

Journalists who write similar articles

(what's this?)

Articles by Andrew Jack published elsewhere

(what's this?)
Tell us about other articles written by Andrew Jack

Find articles by Andrew Jack containing:

Something wrong/missing?

Have we got the wrong information about this journalist? Let us know